Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032
Conference Paper
Full Text
Duke Authors
Cited Authors
- Antonia, SJ; Bendell, J; Taylor, M; Calvo, E; Jaeger, D; de Braud, F; Ott, PA; Pietanza, MC; Horn, L; Le, DT; Morse, MA; Lopez-Martin, JA; Ascierto, PA; Christensen, O; Grosso, JF; Simon, J; Lin, C; Eder, JP
Published Date
- October 1, 2015
Published In
Volume / Issue
- 26 /
Start / End Page
- 74 - 75
Published By
Pages
- 2
Electronic International Standard Serial Number (EISSN)
- 1569-8041
International Standard Serial Number (ISSN)
- 0923-7534
Conference Name
- 17th National Congress of Medical Oncology
Conference Location
- Rome, ITALY
Conference Start Date
- October 23, 2015
Conference End Date
- October 25, 2015